Using this same theory of looking through the old pages of this thread for ideas I have come up with something crazy! on page 50. FEAC. A Blank check Co.... Remember LCA?
No I have to be responsible. The idea was to raise cash today and I will have to be in control and not find anything to buy. So please do not tell me of any great great ideas because I have this cash and it's so hard not to place another chip on the table... No this isn't gambling This is investing. It's different I'm not sure why but it is. FLDM Did I make the right move selling? Question One. Does Van like NVEE? That's question 2. It's steak tonight folks! Big ole' Wagu!
1D chg TYMETyme Technologies, Inc.13.25% PLANAnaplan, Inc.28.40% FLDMFluidigm Corp.26.79%<----------- The number 3 gainer in the whole market. Folks This would be an appropriate time to end this thread\ No one has ever come on Elite Trader and spat out a #1 overall gainer on the Nasdaq and Two Number 3's.... It's unheard of. Now would be the time to step back. There is something out there though called ' The Golden Cycle ' To complete The Golden Cycle I would have to buy a stock that becomes the No 2 overall gainer.. I don't see that happening I feel quite out of ideas. I mean if I could only go back and Buy NIO... NIO might still be the pick after 100%! AGTC.. that Gene play ... wait that's about $5 that would qualify... Back in a bit....
CARR. I liked it at $22. I loved it at $24 I thought it was a really good Idea For Now at $26 and now it's almost $31 and take a look at the chart it looks like one of those moonshots. New company spin out so it's just up straight up. Is still a good idea. TT-- Hey I forgot about Trane still own and like it's in the Ideas Portfolio. AGTC- ?
I would have said yesterday, park about 30% of the funds in $WORK for a short period, but the damn thing is up almost 8% today. Fwiw I have a decent position in it, but I'm also short the Sept 18 $33 calls on the position for $4. Basis is right at $31 so I'm ok.
You are so tricky! You are in Slack I believe but calling it WORK. I don't think either of us know what Slack does. They do have that mysterious division that holds rights to that other company You are also short the stock! My god that's a Slack Spread I believe. Can Slack give me the No 2 position on the board. In order to hit for the Golden Cycle I need a top top gainer... I'm open but I know nothing about this company. Let me look on Youtube. Things are so crazy now I wonder if that Chinese Online company would work? We just talked about it...
Stoney... unbelievable call. From July 30th: Today's news: ____________________________________ Fluidigm’s Covid-19 Saliva Test Receives Emergency FDA Authorization Harriet Lefton August 26, 2020 Fluidigm (FLDM) has announced that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the Advanta Dx SARS-CoV-2 RT-PCR Assay, an extraction-free saliva-based test to detect nucleic acid from the SARS‑CoV‑2 virus. The Covid-19 test is designed to be run on the company’s Biomark HD microfluidics platform. As it is saliva-based, the Advanta Dx SARS-CoV-2 RT-PCR Assay does not require collection via invasive nasopharyngeal swab. The clinical study submitted for the EUA showed 100% agreement between the saliva results from the FLDM assay and the results from paired nasopharyngeal samples. According to FLDM, its microfluidics technology enables processing of more samples per batch than more traditional, microwell plate-based PCR technology. The Biomark HD platform can generate as many as 6,000 test results per day on a single system. “We have seen extraordinarily strong customer interest in our high-throughput saliva-based test, including many new purchases of Biomark HD systems to enable its adoption,” commented Chris Linthwaite, CEO of Fluidigm. “Fluidigm is excited to commercialize this easily administered saliva-based COVID-19 test during a critical phase of the pandemic.” Indeed, Fluidigm was recently selected by the National Institutes of Health for a proposed $37M project under the agency’s Rapid Acceleration of Diagnostics (RADx) program. RADx fast-tracks development and commercialization of innovative technologies to significantly increase U.S. testing capacity for SARS-CoV-2. The Advanta Dx SARS-CoV-2 RT-PCR Assay was developed with scientists at the McDonnell Genome Institute and the Department of Genetics at the Washington University School of Medicine in St. Louis. (See FLDM stock analysis on TipRanks). Shares in FLDM have spiked over 150% year-to-date, and the stock scores a bullish Strong Buy Street consensus. That’s with 3 recent back-to-back buy ratings. Meanwhile the average analyst price target indicates 37% further upside potential from current levels.
LITB-- For no reason was up 20% recently. 8/10 Over a week ago LightInTheBox rises 20.6% 08/19 LITB LightInTheBox is up 20.6%, or 59c to $3.45.<----- Then on 8/19 very good eanings// LightInTheBox Holding reports Q2 earnings per ADS of $0.08 vs ($0.11) year ago; revs +95.9% yr/yr to $113.9 mln Then that Motley Fool [piece.... Now he stock looks bad at $2.42 down almost 5% and daily chart is a mess... But I wonder we can buy this $1 under where it ran to before earnings. And then they went positive 8 cents vs a loss of 11.... Ok maybe these aren't cents these are Chinese coins i don't know but... My spidey sense is telling me that if I want to get the No 2 overall spot I may have to crank up the risk a bit and go with this apparently real Chine online co. VAN-- LITB.
Long the stock, but short the calls. If it explodes on earnings, I'll make like $6ish and lose the position.